Target intelligence / Profile preview

Aldo-keto reductase family 1 member C6, pseudogene (AKR1C6P)

Target
AKR1C6P
Molecular classification
Other
01

Overview

Aldo-keto reductase family 1 member C6, pseudogene (AKR1C6P) is a human pseudogene belonging to the aldo-keto reductase superfamily, a large group of oxidoreductase enzymes that catalyze the reduction of aldehydes and ketones[1][4]. Unlike functional members of this family (e.g., AKR1C1, AKR1C3), AKR1C6P is non-coding and does not produce an active protein. As a pseudogene, it has no demonstrated enzymatic activity, known physiological function, established therapeutic relevance, or well-defined role in disease. Its name and sequence reflect homology to functional AKR enzymes, but it is considered genomically inert and not used as a drug target[3][5]. If you need information on a functional aldo-keto reductase family member for drug targeting or biological research, consider genes and proteins such as AKR1C1, AKR1C2, AKR1C3, etc., which are active enzymes involved in steroid metabolism, cancer, metabolic diseases, and are the focus of significant research and drug development[1][2][4].

Other names
TAKRtruncated aldo-keto reductase

Beyond the preview

Go deeper on Aldo-keto reductase family 1 member C6, pseudogene (AKR1C6P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aldo-keto reductase family 1 member C6, pseudogene (AKR1C6P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call